1-Benzyl-1,2,3,4-Tetrahydro-β-Carboline as Channel Blocker of N-Methyl-d-Aspartate Receptors

Chemical Biology and Drug Design

Volumn 79, Issue 4, 2012, Pages 594-599

  Espinoza Moraga, Marlene ^a,b   Caballero, Julio ^a   Gaube, Friedemann ^b   Winckler, Thomas ^b   Santos, Leonardo S ^a  

^a UNIVERSIDAD DE TALCA   (Chile)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

carboline; Channel blockers; Docking; Excitotoxicity; NMDA receptor

Indexed keywords

1 BENZYL 1,2,3,4 TETRAHYDRO BETA CARBOLINE; BETA CARBOLINE DERIVATIVE; DIZOCILPINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CALCIUM TRANSPORT; CELL DEATH; CHEMICAL STRUCTURE; COMPUTER MODEL; DRUG BINDING; ENANTIOMER; EXCITOTOXICITY; HUMAN; HUMAN CELL; MOLECULAR DOCKING; MOUSE; NONHUMAN; PRIORITY JOURNAL; VESTIBULE;

ALZHEIMER DISEASE; ANIMALS; CARBOLINES; CELL LINE; HUMANS; MICE; MODELS, MOLECULAR; PROTEIN BINDING; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84858799331     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2012.01317.x     Document Type: Article

References (34)

1. Traynelis S.F., Wollmuth L.P., McBain C.J., Menniti F.S., Vance K.M., Ogden K.K., Hansen K.B., Yuan H., Myers S.J., Dingledine R. (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev;62:405-496.
2. Cull-Candy S., Brickley S., Farrant M. (2001) NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol;11:327-335.
3. Childers W.E. Jr, Baudy R.B. (2007) N-methyl-d-aspartate antagonists and neuropathic pain: the search for relief. J Med Chem;50:2557-2562.
4. Collingridge G.L., Lester R.A. (1989) Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev;41:143-210.
5. Reynolds I.J., Miller R.J. (1988) Multiple sites for the regulation of the N-methyl-d-aspartate receptor. Mol Pharmacol;33:581-584.
6. Hu L.Y., Guo J., Magar S.S., Fischer J.B., Burke-Howie K.J., Durant G.J. (1997) Synthesis and pharmacological evaluation of N-(2, 5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-d-aspartate receptor ion-channel blockers. J Med Chem;40:4281-4289.
7. Grauert M., Bechtel W.D., Ensinger H.A., Merz H., Carter A.J. (1997) Synthesis and structure-activity relationships of 6, 7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex. J Med Chem;40:2922-2930.
8. Warncke T., Stubhaug A., Jorum E. (1997) Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain;72:99-106.
9. Burket J.A., Cannon W.R., Jacome L.F., Deutsch S.I. (2010) MK-801, a noncompetitive NMDA receptor antagonist, elicits circling behavior in the genetically inbred Balb/c mouse strain. Brain Res Bull;83:337-339.
10. Parsons C.G., Stoffler A., Danysz W. (2007) Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse. Neuropharmacology;53:699-723.
11. Benveniste M., Mayer M.L. (1993) Multiple effects of spermine on N-methyl-d-aspartic acid receptor responses of rat cultured hippocampal neurones. J Physiol;464:131-163.
12. Cowburn R.F., Wiehager B., Trief E., Li-Li M., Sundstrom E. (1997) Effects of beta-amyloid-(25-35) peptides on radioligand binding to excitatory amino acid receptors and voltage-dependent calcium channels: evidence for a selective affinity for the glutamate and glycine recognition sites of the NMDA receptor. Neurochem Res;22:1437-1442.
13. Benveniste H., Drejer J., Schousboe A., Diemer N.H. (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem;43:1369-1374.
14. Dingledine R., McBain C.J., McNamara J.O. (1990) Excitatory amino acid receptors in epilepsy. Trends Pharmacol Sci;11:334-338.
15. Lipton S.A. (2006) Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov;5:160-170.
16. Turski L., Bressler K., Rettig K.J., Loschmann P.A., Wachtel H. (1991) Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-d-aspartate antagonists. Nature;349:414-418.
17. DiFiglia M. (1990) Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci;13:286-289.
18. Jimenez J., Riveron-Negrete L., Abdullaev F., Espinosa-Aguirre J., Rodriguez-Arnaiz R. (2008) Cytotoxicity of the beta-carboline alkaloids harmine and harmaline in human cell assays in vitro. Exp Toxicol Pathol;60:381-389.
19. Brahmbhatt K.G., Ahmed N., Sabde S., Mitra D., Singh I.P., Bhutani K.K. (2010) Synthesis and evaluation of beta-carboline derivatives as inhibitors of human immunodeficiency virus. Bioorg Med Chem Lett;20:4416-4419.
20. Rook Y., Schmidtke K.U., Gaube F., Schepmann D., Wunsch B., Heilmann J., Lehmann J., Winckler T. (2010) Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents. J Med Chem;53:3611-3617.
21. Shankaraiah N., da Silva W.A., Andrade C.K.Z., Santos L.S. (2008) Enantioselective total synthesis of (S)-(-)-quinolactacin B. Tetrahedron Lett;49:4289-4291.
22. Espinoza-Moraga M., Petta T., Vasquez-Vasquez M., Laurie V.F., Moraes L.A.B., Santos L.S. (2010) Bioreduction of β-carboline imines to amines employing Saccharomyces bayanus. Tetrahedron Asymm;21:1988-1992.
23. Espinoza-Moraga M., Caceres A.G., Santos L.S. (2009) Palladium asymmetric reduction of β-carboline imines mediated by chiral auxiliaries assisted by microwave irradiation. Tetrahedron Lett;50:7059-7061.
24. da Silva W.A., Rodrigues M.T., Shankaraiah N., Ferreira R.B., Andrade C.K.Z., Pilli R.A., Santos L.S. (2009) Novel supramolecular palladium catalyst for the asymmetric reduction of imines in aqueous media. Org Lett;11:3238-3241.
25. Arnold K., Bordoli L., Kopp J., Schwede T. (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics;22:195-201.
26. Low C.M., Lyuboslavsky P., French A., Le P., Wyatte K., Thiel W.H., Marchan E.M., Igarashi K., Kashiwagi K., Gernert K., Williams K., Traynelis S.F., Zheng F. (2003) Molecular determinants of proton-sensitive N-methyl-d-aspartate receptor gating. Mol Pharmacol;63:1212-1222.
27. Kale L., Skeel R., Bhandarkar M., Brunner R., Gursoy A., Krawetz N., Phillips J., Shinozaki A., Varadarajan K., Schulten K. (1999) NAMD2: greater scalability for parallel molecular dynamics. J Comput Phys;151:283-312.
28. MacKerell A.D., Bashford D., Bellott M., Dunbrack R.L., Evanseck J.D., Field M.J., Fischer S. et al. (1998) All-Atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B;102:3586-3616.
29. Tikhonov D.B. (2007) Ion channels of glutamate receptors: structural modeling. Mol Membr Biol;24:135-147.
30. Abagyan R., Totrov M., Kuznetsov D. (1994) ICM - a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation. J Comput Chem;15:488-506.
31. Alzate-Morales J.H., Vergara-Jaque A., Caballero J. (2010) Computational study on the interaction of N1 substituted pyrazole derivatives with B-Raf kinase: an unusual water wire hydrogen-bond network and novel interactions at the entrance of the active site. J Chem Inf Model;50:1101-1112.
32. An J., Totrov M., Abagyan R. (2005) Pocketome via comprehensive identification and classification of ligand binding envelopes. Mol Cell Proteomics;4:752-761.
33. Burnashev N., Schoepfer R., Monyer H., Ruppersberg J.P., Gunther W., Seeburg P.H., Sakmann B. (1992) Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science;257:1415-1419.
34. Bolshakov K.V., Gmiro V.E., Tikhonov D.B., Magazanik L.G. (2003) Determinants of trapping block of N-methyl-d-aspartate receptor channels. J Neurochem;87:56-65.